Prevalence and clinical characteristics of N-terminally truncated WT1 expression in acute myeloid leukemia

Leukemia Research

Volumn 35, Issue 5, 2011, Pages 685-688

  Ishikawa, Yuichi ^a,b   Kiyoi, Hitoshi ^b   Naoe, Tomoki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AML; Leukemia; SWT1; WT1

Indexed keywords

ISOPROTEIN; RNA; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW CELL; CLINICAL EVALUATION; CONTROLLED STUDY; EXON; FETUS; GENE; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; WT1 GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; GENE EXPRESSION REGULATION, LEUKEMIC; GENE FREQUENCY; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MUTANT PROTEINS; PREVALENCE; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; WT1 PROTEINS; YOUNG ADULT;

EID: 79954593152     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.01.002     Document Type: Article

References (8)

1. Yang L., Han Y., Suarez Saiz F., Minden M.D. A tumor suppressor and oncogene: the WT1 story. Leukemia 2007, 21:868-876.
2. Haber D.A., Sohn R.L., Buckler A.J., Pelletier J., Call K.M., Housman D.E. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 1991, 88:9618-9622.
3. Bruening W., Pelletier J. A non-AUG translational initiation event generates novel WT1 isoforms. J Biol Chem 1996, 271:8646-8654.
4. Scharnhorst V., Dekker P., van der Eb A.J., Jochemsen A.G. Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties. J Biol Chem 1999, 274:23456-23462.
5. Dallosso A.R., Hancock A.L., Brown K.W., Williams A.C., Jackson S., Malik K. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours. Hum Mol Genet 2004, 13:405-415.
6. Hossain A., Nixon M., Kuo M.T., Saunders G.F. N-terminally truncated WT1 protein with oncogenic properties overexpressed in leukemia. J Biol Chem 2006, 281:28122-28130.
7. Ozeki K., Kiyoi H., Hirose Y., Iwai M., Ninomiya M., Kodera Y., et al. Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. Blood 2004, 103:1901-1908.
8. Ishikawa Y., Kiyoi H., Tsujimura A., Miyawaki S., Miyazaki Y., Kuriyama K., et al. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia. Eur J Haematol 2009, 83:90-98.